276
Participants
Start Date
August 31, 2002
Primary Completion Date
January 31, 2005
Study Completion Date
December 31, 2008
Double-blind (DB) adalimumab placebo
Double-blind nonactive matching subcutaneous injection
DB adalimumab 40 mg eow
Double-blind adalimumab 40 mg every other week by subcutaneous injection
DB adalimumab 40 mg ew
Double-blind adalimumab 40 mg every week by subcutaneous injection
OL adalimumab 40 mg
Open-label adalimumab every other week or every week by subcutaneous injection
New York Presbyterian Hospital, New York
Daniel Present, New York
Long Island Clinical Research Associates, Great Neck
NY Center for Clinical Research, Lake Success
Rochester Institute for Digestive Diseases, Rochester
Peter Molloy, MD, Pittsburgh
Altoona Center for Clinical Research, Duncansville
Digestive Disorders Associates, Annapolis
Charlottesville Medical Research, Charlottesville
Digestive Health Specialists, Winston-Salem
UNC School of Medicine, Chapel Hill
Charlotte Gastroenterology and Hepatology, Charlotte
Carolina Research Associates, Charlotte
Atlanta Gastroenterology Assoc., Atlanta
Southeastern Digestive & Liver Disease, Savannah
Shafran Gastroenterology Center, Winter Park
Cleveland Clinic Florida, Weston
Wake Research Associates, Weston
Nashville Medical Research Institute, Nashville
Diseases of the Digestive System, Chattanooga
Consultants for Clinical Research, Cincinnati
Wisconsin Center for Advanced Research, Milwaukee
Mayo Clinic and Mayo Foundation, Rochester
Deaconess Billings Clinic Research Division, Billings
Northwest Gastroenterologists, S.C., Arlington Heights
University of Chicago, Chicago
Gastroenterology and Hepatology, Kansas City
Glenn Gordon, MD, Mexico
Gastroenterology Specialties, P.C., Lincoln
Drug Research Services, Inc., Metairie
LSU School of Medicine, New Orleans
Oklahoma Foundation for Digestive Disease, Oklahoma City
Research Solutions, Tulsa
Long Beach Gastroenterology Assoc., Long Beach
Sharp Rees-Stealy Medical Group, San Diego
Gastroenterology Associates of the East Bay, Berkeley
Northwest Gastroenterology, Bellevue
Tacoma Digestive Disease Center, Tacoma
Inland Empire Gastroenterology, Spokane
Gastroenterology Assoc. of Fairfield Co., Bridgeport
Massachusetts General Hospital, Boston
Brigham and Women's Hospital, Boston
Clinical Pharmacology Study Group, Worchester
Lead Sponsor
Abbott
INDUSTRY